1009555-55-8

2,3-DCPE is a proapoptotic compound with selectivity for cancer cells versus normal human cells. It induces apoptosis in vitro in various cancer cell lines (IC₅₀s = 0.89-2.69 μM) more effectively than in normal human fibroblasts (IC₅₀ = 12.6 μM). 2,3-DCPE down-regulates Bcl-xL, however forced overexpression of Bcl-xL is sufficient to block 2,3-DCPE apoptosis induction. 2,3-DCPE can induce S-phase arrest, upregulate p21, and activate ERK.

2,3-DCPE is a compound that induces both upregulation and S-phase arrest in p21. Used as an anti-cancer treatment as it induces apoptosis.

Desiccate at -20°C

[1] SHUHONG WU. Induction of apoptosis and down-regulation of Bcl-XL in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol.[J]. Cancer research, 2004, 64 3: 1110-1113. DOI: 10.1158/0008-5472.can-03-2790
[2] HONGBO ZHU. Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK[J]. Oncogene, 2004, 23 29: 4984-4992. DOI: 10.1038/sj.onc.1207645